Back to UBS Group AG UBS Group AG

RNTXRNTX
14 quarters

Position history for UBS Group AGUBS Group AG's holdings in REIN THERAPEUTICS INC

UBS Group AG holds 1,024 shares of RNTX (REIN THERAPEUTICS INC), worth $1,331 as of 2026-Q1. The position was decreased (-89.2% shares).

Current Value

$1,331

Current Shares

1,024

Total Value Change

-$6,518

Total Shares Change

-2,288

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1,024
-89.2%
$1,3310.0%$1.15
0
2025-Q4
Increased
9,516
+114x
$11,0390.0%$1.07
19
2025-Q3
Decreased
83
-99.5%
$950.0%$1.15
0
2025-Q2
Increased
15,701
+426.9%
$21,9810.0%$1.47
21
2025-Q1
Decreased
2,980
-58.9%
$5,2750.0%$1.70
0
2024-Q4
New
7,251
-
$16,6770.0%$2.32
28
2024-Q3
Exited
0
-100.0%
$00.0%$3.65
0
2024-Q2
Increased
3,145
+3281.7%
$8,7120.0%$2.77
18
2024-Q1
Decreased
93
-95.7%
$6170.0%$6.63
0
2023-Q4
New
2,144
-
$6,5370.0%$3.05
24
2023-Q3
Exited
0
-100.0%
$00.0%$1.52
0
2023-Q2
Increased
1,357
+1257.0%
$2,4290.0%$1.78
13
2023-Q1
Decreased
100
-97.0%
$1240.0%$1.26
0
2022-Q4
New
3,312
-
$7,8490.0%$2.37
25

Other major holders of RNTX: Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used